2 completed, 2 withdrawn. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Multifocal Choroiditis: new trials by email Literature Review of Multifocal Choroiditis trials Research Report on Multifocal Choroiditis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis Bevacizumab - Punctate Inner Choroidopathy | Completed | Changhua Christian Hospital | 14 | 2018-10-01 | 2019-04-01 | |
| Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Bevacizumab (Avastin; Genentech, Inc.), Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy - Choroidal Neovascularization, Myopia | Not applicable | Withdrawn | Massachusetts Eye and Ear Infirmary | 2010-08-01 | 2014-01-14 | |
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
| Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Bevacizumab, Intravitreal Injection of Bevacizumab - Vogt Koyanagi Harada Disease, Serpiginous Choroiditis | Phase 3 | Withdrawn | Asociación para Evitar la Ceguera en México | 2006-12-01 | 2024-05-30 |
White Dot Syndromes (3) · Uveitis (2) · Angioid Streaks (1) · Behcet Syndrome (1) · Birdshot Chorioretinopathy (1) · Central Serous Chorioretinopathy (1) · Choroidal Neovascularization (1) · Eye Diseases, Hereditary (1) · Myopia (1) · Ophthalmia, Sympathetic (1) · Panuveitis (1) · Retinal Vasculitis (1) · Sarcoidosis (1) · Uveitis, Intermediate (1)
Choroid Diseases (4) · Choroiditis (4) · Eye Diseases (4) · Uveal Diseases (4) · Panuveitis (3) · Uveitis, Posterior (3) · Autoimmune Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Immune System Diseases (2) · Retinal Diseases (2) · Uveitis (2) · Autoimmune Diseases of the Nervous System (1) · Cardiovascular Diseases (1) · Chorioretinitis (1)
Bevacizumab (3) · Dexamethasone (1) · secukinumab (1)
Asociación para Evitar la Ceguera en México (1) · Changhua Christian Hospital (1) · Massachusetts Eye and Ear Infirmary (1) · Novartis Pharmaceuticals (1)
Germany (1) · Mexico (1) · Taiwan (1) · United States (1)
Ivana K Kim, MD (1) · LuzElena Concha-Del Rio, MD (1) · Veronica Kon-Jara, MD (1)